- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Gout
The Rheumatology Network gout clinical focus page provides information on the latest gout news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for gout drugs.
Rheumatology Network's Top 5: May 14, 2022
May 14, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending May 14, 2022.
Healthy Lifestyle Modifications May Lower Risk of Genetically Induced Gout
May 11, 2022
While genetics are linked to gout diagnosis and lifestyle factors are related to risk, the association between healthy choices and risk mitigation remained unclear.
Gout Increases Risk of COVID-19-Related Death in Women
April 13, 2022
“Understanding the drivers of this increased risk in women with gout warrants further investigation in larger datasets," investigators stated.
Jeff Peterson, MD: FDA Announces Priority Review of Pegloticase Plus Methotrexate for Gout Treatment
April 05, 2022
Jeff Peterson, MD, explains the importance of the recent FDA announcement granting priority review of the Supplemental Biologics License Application for concomitant use of pegloticase injection (KRYSTEXXA) plus methotrexate for patients with uncontrolled gout.
Rheumatology Network's Top 5: April 2, 2022
April 02, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending April 2, 2022.
Self-Management App Improves Urate Levels in Patients With Gout
April 01, 2022
Supported self-management approaches have been shown to benefit patients with chronic health conditions, including gout.
Coffee Consumption Reduces Risk of Gout
March 29, 2022
“The effects of coffee consumption on SUA levels and gout risk are controversial,” investigators explained. “There have hitherto been no reports based on its effects that consider pleiotropy.”
Robert Terkeltaub, MD: Safety and Efficacy of Tigulixostat in Gout Treatment
November 23, 2021
Robert Terkeltaub, MD, explains the results from a phase 2, dose-finding study to determine the safety and efficacy of tigulixostat in patients with gout.
Jeff Peterson, MD: Majority of Patients With Gout Achieved Complete Response Rate With Combination Pegloticase and Methotrexate
November 11, 2021
Jeff Peterson, MD, discusses his study determining the complete response rate of pegloticase in conjunction with methotrexate.
Kazuki Yoshida, ScD: Gout Treatment Strategies Regarding Cardiovascular Outcomes
November 05, 2021
Kazuki Yoshida, MD, MPH, ScD, discusses his ACR presentation entitled, “Comparative Safety of Gout "Treat-to-target" and "Usual Care" Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Causal Inference Approach.”